Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abacus Global Management, Inc. - Class A Common Stock (NQ:ABL)

8.585 +0.075 (+0.88%)
Streaming Delayed Price Updated: 10:07 AM EST, Dec 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abacus Global Management, Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Mendon Capital Bets Big on Regional Bank, According to SEC Filing ↗
Mendon Capital bought nearly $7.8 million worth of Simmons First National stock during the third quarter. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Follow the Money: Regional Bank Stock Sees Sizable Buy Ticket From Fund ↗
Mendon Capital bought more than $7.6 million worth of FB Financial stock during the third quarter. 
Via The Motley Fool
Topics Regulatory Compliance
Exclusive: Abacus Global CEO Jay Jackson Eyes Billions In AUM, Explains How The Company Plans To Bridge The Valuation Disconnect ↗
Via Stocktwits
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Preview: Abacus Life ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Wondering what's happening in today's pre-market session? ↗
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
News headline image
Abacus Global Management Shares Jump After Announcing Buyback Plan And Insider Purchases ↗
Abacus Global Management Inc. (NASDAQ: ABL) shares are trading higher Friday after the company announced a $20 million share repurchase program and disclosed insider buying totaling over $2 million. 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Uncovering Potential: Abacus Life's Earnings Preview ↗
 
Via Benzinga
News headline image
What's going on in today's session ↗
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Which stocks are experiencing notable movement on Wednesday? ↗
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
Traders are paying attention to the gapping stocks in Friday's session. ↗
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
Argan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Lamb Weston Posts Weak Q2 Results, Joins Micron, Lennar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 27, 2025 ↗
 
Via Benzinga
News headline image
Abacus Life’s CEO on Cracking the Code of Longevity Returns
With its data-driven approach Abacus Life unlocks the hidden value in life insurance policies, transforming overlooked assets into market-beating returns. 
Via MarketBeat
News headline image
ABL Stock Earnings: Abacus Life Beats EPS, Beats Revenue for Q2 2024 ↗
ABL stock results show that Abacus Life beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Western Alliance Posts Upbeat Earnings, Joins Abacus Life, SLB And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Why Is Professional Diversity Network (IPDN) Stock Down 22% Today? ↗
Professional Diversity Network stock is down on Friday with heavy trading of IPDN shares despite a lack of news from the company. 
Via InvestorPlace
News headline image
Why Is Abacus Life (ABL) Stock Down 18% Today? ↗
Abacus Life stock is down on Friday after the company priced a public offering for 10 million shares of ABL at $8 each. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! 
Via InvestorPlace
News headline image
Smith & Wesson Brands, Abacus Life And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.